HLA CELIAC DISEASE (DQB1*02, 1*03, DQA1*05;01)

HLA‑DQA1*05 positive means you carry a specific HLA class II gene variant that influences immune recognition. Carriers are more likely to form anti‑drug antibodies to some biologic therapies (for example anti‑TNF agents), which can lower drug effectiveness and raise risk of reactions. Paired with other HLA alleles it also increases celiac disease risk; clinicians may adjust treatment and monitoring accordingly.

HLA‑DQA1 *02 denotes a specific allele family of the HLA‑DQA1 gene, which encodes the alpha chain of the MHC class II DQ molecule. The *02 label identifies a group of closely related genetic variants (e.g., *02:01) that influence antigen presentation. These inherited variants can affect immune responses, susceptibility to autoimmune diseases, and compatibility for organ or stem‑cell transplantation.

DQ2 DQA1*05:01/*05:05 with DQB1*02:xx denotes HLA‑DQ2 genotypes that form the DQ2 heterodimer. This haplotype is the main genetic predisposition for celiac disease: its presence markedly raises risk but is not diagnostic (many carriers remain healthy). Absence makes celiac unlikely. Results must be interpreted with symptoms and serology/biopsy; genetic testing can aid family screening and diagnostic exclusion.

HLA-DQ refers to immune-system genes (HLA-DQ2 and HLA-DQ8) that present gluten fragments to T cells and are strongly associated with celiac disease. Nearly all people with celiac carry DQ2 or DQ8, so testing helps rule out disease if both are absent. However, many carriers never develop celiac, so positive results support but do not confirm diagnosis and are used with serology and biopsy.

HLA‑A*02 positive means you carry the HLA‑A*02 variant of the human leukocyte antigen (HLA) class I gene. HLA proteins on cell surfaces help the immune system distinguish self from foreign. Carrying HLA‑A*02 affects transplant compatibility, immune responses to infections and vaccines, and can associate with certain disease risks or drug responses. It is an inherited genetic marker.

HLA‑DQ2 or DQ8 alleles are necessary but not sufficient for celiac disease: about 30–40% of people carry these alleles, yet only roughly 1% develop the disease. Carrying DQ2/DQ8 raises risk, notably in first‑degree relatives (≈10% risk). A negative HLA‑DQ2/DQ8 test makes celiac disease very unlikely, but a positive result alone does not confirm diagnosis.